Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex in End-Stage Renal Failure
NCT01785758Phase 4Completed
- Sponsor
- Federal University of São Paulo
- Start
- Oct 2011
- Primary completion
- Jan 2012
- Modality
- Biodegradable Polymers, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Sugammadex in neuromuscular blockade (NMB), sponsored by Federal University of São Paulo. Started Oct 2011; status: completed.
02
Drugs
Sugammadex
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT01785758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01785758.